BIOSPYDER TECH INC has a total of 13 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, United Kingdom and Canada. Its main competitors in its focus markets biotechnology are GUANGZHOU SUREXAM BIO TECH CO, PHARMASSIST LTD and FUJIAN MEDICAL UNIVERSITY UNION HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | United Kingdom | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Singapore | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Seligmann Bruce | 11 |
#2 | Yeakley Joanne M | 10 |
#3 | Mccomb Joel | 8 |
#4 | Stevens Anthony | 6 |
#5 | Bruce Seligmann | 2 |
#6 | Babic Milos | 2 |
#7 | Shepard Peter J | 2 |
#8 | Anthony C Stevens | 2 |
#9 | Joanne M Yeakley | 2 |
#10 | Joel Mccomb | 2 |
Publication | Filing date | Title |
---|---|---|
US2020385816A1 | TempO-Seq | |
WO2018176007A1 | Modulation of targets in cellular pathways identified by resolution of stochastic gene expression | |
US2018223343A1 | Profiling expression at transcriptome scale | |
US2017101671A1 | Ligation assays in liquid phase | |
US2016222447A1 | Ligation assays in liquid phase | |
US2016068886A1 | Attenuators |